iHealthClinical’s Post

Raising Lung Cancer Awareness: The Crucial Role of Early Screenings Lung cancer remains one of the leading causes of cancer-related deaths worldwide. According to the World Health Organization (WHO), it accounts for approximately 18% of all cancer deaths. The journey to improving patient outcomes begins with awareness—understanding the disease, recognizing risk factors, and acknowledging the value of early screenings. This article aims to highlight the surging incidence of lung cancer among smokers and non-smokers alike, provide insights into signs and symptoms, explore treatment options and staging, and examine ongoing disparities across sex, age, and race. The Rising Incidence of Lung Cancer Lung cancer primarily manifests in two main forms: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). A significant correlation exists between smoking and the likelihood of developing lung cancer, with smokers facing a risk up to 20 times higher than non-smokers. The American Cancer Society estimates that as of 2023, about 236,740 new cases of lung cancer will be diagnosed, with approximately 130,180 deaths—a grim reminder of the disease's lethality. Despite common misconceptions, lung cancer does not exclusively affect smokers. Recent studies indicate an alarming increase in pneumonia and lung cancer diagnoses among non-smokers due to environmental exposures, genetic predisposition, and other factors. This includes individuals exposed to secondhand smoke, radon gas, and industrial pollutants. For healthcare providers, understanding this statistic is crucial when assessing patients presenting with respiratory symptoms. Recognizing the Signs and Symptoms The challenge lies in the often-late presentation of lung cancer symptoms. Early-stage lung cancer may not exhibit clear signs, which is why awareness is paramount. As the disease progresses, subtle symptoms may develop, including: - **Persistent Cough**: A cough that doesn’t go away or worsens over time. - **Chest Pain**: Discomfort that may be persistent or occur with deep breathing, coughing, or laughing. - **Shortness of Breath**: Difficulty breathing or a feeling of being out of breath during simple activities. - **Unexplained Weight Loss**: Significant weight loss without trying can be a concerning sign. - **Fatigue**: Persistent fatigue or weakness, often accompanied by general malaise. Recognizing these symptoms and encouraging prompt medical consultation is essential for effective intervention. Medical professionals should educate their patients on the importance of reporting any unusual respiratory changes.

📃Scientific paper: Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave Abstract: SIMPLE SUMMARY: The COVID-19 pandemic continues, and cancer patients are at high risk for both contracting as well as dying from the infection. There is not as much data known about newer COVID-19 variants such as Omicron compared to earlier waves for patients with cancer. In this study, we retrospectively evaluated how COVID-19 positivity affected both patients and their providers in our community-facing cancer clinic. We found that 33.3% compared to 8.7% of cancer providers versus patients, respectively, tested positive for COVID-19 from December 2021 through April 2022 (p = 0.038). Furthermore, we saw that almost two-thirds of cancer patients experienced delays in receiving cancer treatments. Finally, over 10% of cancer patients (4 of 90) died during the Omicron wave. This study confirms that COVID-19 remains a formidable infection in terms of cancer patients’ treatment as well as livelihood, and continues to result in considerable health care disparities for disadvantaged populations. ABSTRACT: (1) Background: the SARS-CoV-2 (COVID-19) pandemic continues, and patients actively receiving chemotherapy are known to be at enhanced risk for developing symptomatic disease with poorer outcomes. Our study evaluated the prevalence of COVID-19 among patients and providers of our community-facing county health system during the B1.1.529 (“Omicron”) COVID-19 variant wave. (2) Methods: We retrospectively analyzed patients that received care and clinical providers whom worke... Continued on ES/IODE ➡️ https://etcse.fr/kes ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.

Esophageal cancer awareness is a crucial topic that deserves attention. Spreading awareness about this disease improves early detection and treatment outcomes. Esophageal cancer occurs when malignant cells form in the tissues of the esophagus, the muscular tube that connects the throat to the stomach. There are several risk factors associated with esophageal cancer, including tobacco use, heavy alcohol consumption, obesity, and certain medical conditions such as gastroesophageal reflux disease (GERD) and Barrett's esophagus. Individuals need to be aware of these risk factors and take steps to reduce their risk. Symptoms of esophageal cancer can vary and may include difficulty swallowing, chest pain, weight loss, and persistent heartburn. It is essential to consult a healthcare professional for further evaluation if any of these symptoms are present. Early detection of esophageal cancer is critical to improving treatment outcomes. Regular screenings and diagnostic tests can help identify the disease in its early stages when it is more treatable. Treatment options for esophageal cancer may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. In addition to promoting awareness, it is also essential to support individuals affected by esophageal cancer. This can be done through fundraising events, support groups, and educational resources. By raising awareness about esophageal cancer, we can help ensure that individuals at risk are informed about the disease and have access to the necessary resources for prevention, early detection, and treatment. Together, we can make a difference in the fight against esophageal cancer.

Today, on National Cancer Awareness Day, we stand united in the fight against cancer. At Ampin's Pharma, we are dedicated to advancing regulatory services that ensure the safety and efficacy of cancer treatments and to provide regulatory services that uphold the highest standards for cancer therapies. Let's continue to support research, spread awareness, and work towards a future free from cancer, We're very inspired by the resilience of those affected by cancer and driven to ensure that safe, effective treatments reach those who need them. National Cancer Awareness Day reminds us all of the ongoing journey to better treatment options and greater awareness. Together, let's raise our voices and drive change, Together, we can make a difference.! Here are some essential tips for cancer awareness that can help individuals and communities take proactive steps for prevention, early detection, and support: 1. Understand Risk Factors - Know lifestyle and environmental factors that can increase cancer risk, such as smoking, alcohol consumption, poor diet, and exposure to harmful chemicals.    - Family history can also play a role; discuss hereditary risks with your healthcare provider if applicable. 2. Adopt a Healthy Lifestyle - Maintain a balanced diet rich in fruits, vegetables, and whole grains. - Engage in regular physical activity and maintain a healthy weight. - Avoid tobacco and limit alcohol intake, both of which are linked to various cancers. 3. Prioritize Regular Screenings - Early detection is critical. Regular screenings, like mammograms, pap smears, colonoscopies, and skin exams, can help detect cancer early when it is more treatable. - Follow guidelines from healthcare providers based on age, gender, and family history. 4. Protect Your Skin - Skin cancer is one of the most common forms of cancer. Use sunscreen with at least SPF 30, avoid tanning beds, and wear protective clothing when in the sun. - Regularly check your skin for any changes in moles or spots, and consult a dermatologist if you notice any abnormalities. 5. Vaccinate - Vaccines like HPV and hepatitis B can prevent infections linked to cancers, such as cervical and liver cancer. 6. Stay Informed and Educated - Knowledge is power. Stay updated on cancer prevention, symptoms, and treatment options through reliable health sources. - Understand symptoms like unexplained weight loss, fatigue, lumps, or persistent pain, and never hesitate to consult a healthcare professional if something feels off. Each step towards awareness and proactive health habits brings us closer to a world where more cancers are preventable or treatable. Spread the word, take action, and make a difference..!👍 If you like our posts, Be a connection with Ampin's Pharma and make sure to on notification of our profile to get informed for all our upcoming new posts.! #Ampin #Ampinspharma #AmpinsDrugRegulatoryServices

National Cancer Awareness Day (November 7 in India): Focusing on Oral Cancer and the Crucial Role of Oral Medicine Specialists Observed on November 7 each year, India’s National Cancer Awareness Day is dedicated to raising awareness about cancer, promoting early diagnosis, and encouraging proactive measures to prevent and combat the disease. This day highlights the importance of cancer education and the need for regular health check-ups, especially in a country where cancer incidence is steadily rising. Oral cancer is one of the most prevalent types of cancer in India, largely driven by the widespread use of tobacco in various forms, along with alcohol consumption and HPV infection. Oral cancer often manifests subtly at first, with symptoms such as non-healing sores, red or white patches, lumps, or persistent pain. Because these signs are often overlooked or mistaken for less serious issues, oral cancer frequently goes undetected until it reaches advanced stages, when treatment is more challenging. This underscores the vital role of oral medicine specialists in the early detection of oral cancer. As experts in diagnosing oral cavity diseases, these specialists can identify early warning signs and perform critical screenings. Their expertise enables timely referrals for treatment, improving survival rates and reducing the impact of the disease. Additionally, oral medicine specialists provide preventive education to help patients understand the risks associated with tobacco, alcohol, and other factors, empowering them to make healthier choices. On National Cancer Awareness Day, let’s recognize the importance of regular oral screenings and the essential contribution of oral medicine specialists in the fight against oral cancer. By raising awareness and supporting preventive care, we can work towards a healthier future and reduce the burden of oral cancer across India.

It's Colon Cancer Awareness Month, and there's no better moment to spotlight the importance of proactive measures against this preventable disease. Dr. Kate Sowerwine, Recuro's Chief Medical Officer, emphasizes the critical need to prioritize your colon health, starting from the comfort of your home. Dive into the essential facts and preventative measures in our latest blog, curated by Dr. Sowerwine: https://hubs.li/Q02qdNkh0. ● Understanding Colorectal Cancer: Colorectal cancer is a preventable disease, yet screening can be challenging. In our latest article, we dive head-on into when to start regular screenings and how our at-home colon cancer screening test works. ● Industry Statistics Update: In 2023 alone, there were over 153,000 new cases of colorectal cancer, resulting in more than 52,000 deaths in the US. This staggering reality underscores the critical need for spreading awareness and early detection. At Recuro Primary Care, we offer comprehensive screening solutions to our patients, ensuring proactive care and timely intervention. With Recuro, you can be seen by a PCP in as little as 24-48hrs, not weeks or months! ● Recognizing Symptoms: Colorectal cancer may not always exhibit symptoms, making screenings all the more crucial. Keep an eye out for changes in bowel habits, blood in stool, persistent pain, and unexplained weight loss. ● Start Screening at 45: Most individuals should commence screening at the age of 45, although earlier screenings may be necessary for those with specific risk factors such as family history or inflammatory bowel disease. Consult with your doctor to establish a personalized screening plan tailored to your needs. ● Convenient At-Home Testing: Empower yourself with our at-home colorectal cancer test. It's noninvasive, accurate, and designed to make screening more accessible and less intimidating. Recuro Primary Care also offers screenings for other serious diseases, all from the comfort of your own home. ● Embrace Early Detection: Research demonstrates that early detection significantly improves outcomes, boasting a 90.9% survival rate when colorectal cancer is caught early. Don't wait until it's too late – schedule your Recuro Primary Care appointment today: https://hubs.li/Q02qdNsJ0 Ready to Book? Kickstart your journey to better health by logging into our member portal or downloading the Recuro Care app https://hubs.li/Q02qdRZp0. Let's prioritize your well-being together! Learn more about the dangers of Colorectal Cancer at https://hubs.li/Q02qdNkh0. Together, We're Making Advanced Healthcare Accessible™. Join us in spreading awareness and promoting proactive measures against colorectal cancer this March. Phil Fasano Michael Brombach Kate Sowerwine MD Kimberly Darling Matthew Turrin, CPA Allison Martin Josh Nordtvedt Quinn Pearl Jon O'Toole Daniel Wang

International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes. Here are key guidelines to follow: 1. Identify the Primary Malignancy - When coding for cancer, always identify the primary site where the malignancy originated. - Use codes from category C00-C75 to represent the specific site of the primary malignancy. - If the primary site is unknown, use -C80.1 (Malignant (primary) neoplasm, unspecified). 2. Determine if the Cancer is Active or Historical- - Active cancer indicates the patient is currently undergoing treatment or the cancer is still present. Use the appropriate code from categories C00-C97. - If cancer is no longer present and the patient is not receiving treatment, use a history code such as Z85.xx (Personal history of malignant neoplasm). 3. Code Secondary Malignancies - When cancer spreads to other sites (metastasis), assign a code for the primary site first, followed by the code for the secondary (metastatic) site. - Use codes from category C77-C79- to indicate secondary malignancies. 4. Use Additional Codes for Treatment Complications** - If a patient is experiencing complications due to cancer treatment (e.g., chemotherapy-induced neutropenia), use additional codes to describe the complication. - For example, use D70.1 (Agranulocytosis secondary to cancer chemotherapy) if the patient develops agranulocytosis as a result of chemotherapy. 5. apply Proper Sequencing for Chemotherapy, Radiotherapy, or Immunotherapy - When a patient is receiving treatment solely for chemotherapy, radiotherapy, or immunotherapy, the appropriate Z code should be the first-listed code: - Z51.11 (Encounter for antineoplastic chemotherapy) - Z51.12 (Encounter for antineoplastic immunotherapy) - Z51.0 (Encounter for radiotherapy) - The active cancer diagnosis should follow the Z code. 6. Code Symptoms and Manifestations - When a patient presents with symptoms due to cancer but has not yet received a definitive diagnosis, code the symptoms [e.g., R07.1 (Chest pain, unspecified)] until the cancer diagnosis is confirmed. - Once a diagnosis is confirmed, code the malignancy instead of the symptom. 7.Code Neoplasms of Uncertain Behavior or Carcinoma In Situ** - Use codes from category D37-D48- for neoplasms of uncertain behavior when a neoplasm is not clearly benign or malignant. - Use codes from category D00-D09-for carcinoma in situ (CIS), which describes a localized cancer that has not invaded surrounding tissue. #MedicalCoding #Neoplasm #HealthcareBilling #ICD10 #CPTCode #icd10 #cpt #medicalbilling #MedicalCoding #cancer #HealthcareBilling #ICD10 #CPTCoding #HealthcareManagement #HealthcareAdministration #MedicalBilling #HealthcareIndustry #HealthcareProfessionals

Oncovir is having a great week with two exciting updates. First, our product (Hiltonol PolyICLC) is featured in a GritDaily article that highlights Oncovir’s strategic positioning in Oncology and infectious disease. The article covers product position and recent trials using Hiltonol as a stand-alone therapy and as an adjuvant. Second, exciting news emerges from a groundbreaking study featured in Nature Communications. In a Phase II clinical trial, the integration of Hiltonol with ATL-DC vaccination showcased remarkable efficacy in patients grappling with newly-diagnosed or recurrent malignant gliomas. This trial builds upon previous research, reaffirming Hiltonol's status as a potent adjuvant. Notably, patients administered with Hiltonol exhibited statistically significant boosts in overall median survival rates, signifying a promising advancement in glioma treatment. We encourage you to read these exciting articles and share them with anyone who may find them useful. https://lnkd.in/ezhbHpe9 https://lnkd.in/eVy45VeE

🏡 𝐁𝐄𝐓𝐀. 𝐇𝐄𝐀𝐋𝐓𝐇 𝐱 𝐑𝐨𝐜𝐡𝐞 𝐩𝐫𝐨𝐣𝐞𝐜𝐭 𝐚𝐢𝐦𝐬 𝐭𝐨 𝐛𝐫𝐢𝐧𝐠 𝐜𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐫𝐞 𝐢𝐧𝐭𝐨 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬’ 𝐡𝐨𝐦𝐞𝐬. ‘Blood Tests at Home’, the healthcare innovation project selected from our ‘Industry Call’ in partnership with Roche Danmark last summer, aims to enhance the quality of life for cancer patients by bringing care into their homes while also freeing up hospital resources for other important tasks. Before beginning chemotherapy, patients undergo blood tests to ensure they have adequate levels of white blood cells, platelets, hemoglobin and immune system function. Today, these blood tests must be done in hospital – and some patients require ongoing testing three to four times a week. Such frequent hospital visits place significant demands on patients and their caregivers. The Blood Tests at Home project aims to improve the quality of life for cancer patients and their caregivers through a new technology that enables them to perform these critical blood tests at home, eliminating the burden of multiple weekly hospital visits. In collaboration with partners in Germany and Poland, the team behind Blood Tests at Home is piloting a home-testing solution with 150 cancer patients from five hospitals located in Denmark, Germany and Poland. With this solution, the patient pricks their finger and completes a few simple steps to prepare the sample before inserting it into a scanner. When the results are ready, the patient photographs and submits them via the system’s dedicated health platform. The final iteration of the solution, which is under development, will be fully automated to send the results directly to the hospital. The team believes that this solution will make life easier for cancer patients undergoing chemotherapy by reducing the number of hospital visits – and the risk of infection inherent in those visits. ‘In practical terms, it can help patients spend more time at home with their loved ones instead of travelling to central laboratories for blood tests. That's how it's done today. This is a new way of thinking, where diagnostic equipment is brought into patients' homes’, explains Niels Henrik Holländer, Chief Physician in the Oncology Department at Sjællands Universitetshospital in Næstved, and a member of the project team behind Blood Tests at Home along with Keld Hundewadt. The team’s ambition is to develop a solution that enhances patient treatment, improves their quality of life and benefits the overall healthcare system in Denmark – but which can also be scaled and extended to all other types of cancer patients with similar needs in Europe and the rest of the world.

Lung Cancer Awareness Month: A Call to Action for November 2024 November is not just a month of falling leaves and the approach of winter; it is also dedicated to an equally vital cause: Lung Cancer Awareness Month. This annual observance aims to raise awareness about lung cancer, its risk factors, symptoms, and the importance of early detection. As we approach November 2024, it is crucial to understand the implications of this disease and how individuals and communities can take action to combat it. Understanding Lung Cancer Lung cancer is the leading cause of cancer mortality worldwide, with millions diagnosed annually. Risk Factors While smoking remains the most significant risk factor for lung cancer, accounting for about 85% of cases, there are several other factors to consider: 1. **Secondhand Smoke:** Even non-smokers can be affected by exposure to secondhand smoke, increasing their risk of lung cancer. 2. **Occupational Hazards:** Certain professions expose individuals to carcinogens such as asbestos, radon, and chromium, which are linked to higher incidences of lung cancer. 3. **Air Quality:** Poor air quality can also contribute to lung cancer risk. Long-term exposure to polluted air can lead to cellular damage and mutations in lung tissues. 4. **Genetics:** Family history can play a role, with certain genetic mutations increasing susceptibility to lung cancer. 5. **Chronic Lung Diseases:** Conditions like chronic obstructive pulmonary disease (COPD) or previous lung infections can elevate the risk Early detection is crucial for improving survival rates in lung cancer patients. However, symptoms often do not appear until the disease has progressed. Some common symptoms include: - Persistent cough that doesn't go away - Coughing up blood or rust-colored sputum - Chest pain, especially during deep breathing, coughing, or laughter - Hoarseness and wheezing - Unexplained weight loss - Fatigue and weakness - Repeated respiratory infections (like bronchitis or pneumonia) As we enter Lung Cancer Awareness Month in November 2024, it is essential for individuals, families, and communities to unite in the fight against lung cancer. Awareness leads to action, which can foster early detection, better support, and ultimately, save lives. Engage in local events, share essential information with friends and family, advocate for policy changes, and support research funding. Each small effort contributes to a broader understanding of the disease and its impact, helping pave the way to a future where lung cancer is no longer a leading cause of cancer death. Let’s make November a month to remember, not just for falling leaves, but for hopeful strides in combating lung cancer and standing in solidarity with those affected by this life-altering disease. Throughout the month, let us raise our voices, share our stories, and advocate for those who cannot. Together, we can make a difference.